NCT07186140View on ClinicalTrials.gov

Clinical Features, Treatments, and Outcomes in Acute Respiratory Distress Syndrome (ARDS-CTO)

Not yet recruitingOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions
Acute Respiratory Distress Syndrome (ARDS)
Trial Locations (1)

05505

Asan Medical Center, Seoul

All Listed Sponsors
lead

Jee Hwan Ahn

OTHER

NCT07186140 - Clinical Features, Treatments, and Outcomes in Acute Respiratory Distress Syndrome (ARDS-CTO) | Biotech Hunter | Biotech Hunter